View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
April 14, 2020

VUNO receives approval for AI-based screening device

VUNO, a Born2Global Centre member company, has secured Class III medical device approval from the Korean Ministry of Food and Drug Safety for its VUNO Med-Fundus artificial intelligence (AI) screening solution.

VUNO, a Born2Global Centre member company, has secured Class III medical device approval from the Korean Ministry of Food and Drug Safety for its VUNO Med-Fundus artificial intelligence (AI) screening solution.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Clinically proven to deliver highly accurate screening results, VUNO Med-Fundus AI is considered to be the first-ever AI device to gain a Class III approval in Korea.

By analysing retinal fundus images, the device can detect and locate more than 12 lesions within one second. The findings detected include haemorrhage, hard exudate, chorioretinal atrophy or scar, vascular abnormality, retinal nerve fibre layer defect and glaucomatous disc change.

Additionally, it encompasses all findings that are important in diagnosing retinal diseases, including diabetic retinopathy, macular degeneration and glaucoma.

The examination is performed to observe the state of the fundus that plays a significant role in eyesight. Fundus is made up of the retina, optic nerve and retinal blood vessels.

This procedure helps in the early detection of diseases such as diabetic retinopathy, macular degeneration and glaucoma that may lead to loss of sight.

VUNO Med-Fundus AI was developed based on a large-scale deep learning dataset of more than 100,000 fundus images.

More than 50 ophthalmologists, including 28 specialists, examined the images.

An external validation exam, incorporating multi-ethnic, multi-centre settings, verified a stable performance by the solution matching that of retina specialists.

A research paper published in Ophthalmology revealed that the solution’s clinical validation (AUROC) of the 12 findings resulted in an impressive range of 96.2% to 99.9%, and 94.7% to 98.0% with external datasets.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network